Selected research
Industry Research
EMOCAP Industry Research Report 2026
Market perspective
The global EMOCAP market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the EMOCAP market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the EMOCAP market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the EMOCAP market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of EMOCAP include StretchSense, Noitom, Vicon, Cyber Glove Systems, Rokoko, MANUS, AiQ Synertial, Virtual Motion Labs and PhaseSpace, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global EMOCAP market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to EMOCAP.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
EMOCAP Market by Company
StretchSense
Noitom
Vicon
Cyber Glove Systems
Rokoko
MANUS
AiQ Synertial
Virtual Motion Labs
PhaseSpace
VRTRIX
HaptX
Virdyn
Qualisys AB
Xsens Technologyes
Optitrack
Codamotion
PTI Phoenix Technologies
Noraxon USA
NTT Data
EMOCAP Segment by Type
Whole Boby
Part Boby
EMOCAP Segment by Application
Scientific Research
Entertainment
Medical
Other
EMOCAP Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EMOCAP market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of EMOCAP and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EMOCAP.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of EMOCAP companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Whole Boby
- Part Boby
Applications
- Scientific Research
- Entertainment
- Medical
- Other
Companies covered
- StretchSense
- Noitom
- Vicon
- Cyber Glove Systems
- Rokoko
- MANUS
- AiQ Synertial
- Virtual Motion Labs
- PhaseSpace
- VRTRIX
- HaptX
- Virdyn
- Qualisys AB
- Xsens Technologyes
- Optitrack
- Codamotion
- PTI Phoenix Technologies
- Noraxon USA
- NTT Data
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 EMOCAP by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Whole Boby
- 2.2.3 Part Boby
- 2.3 EMOCAP by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Scientific Research
- 2.3.3 Entertainment
- 2.3.4 Medical
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 EMOCAP Breakdown Data by Type
- 3.1 Global EMOCAP Historic Market Size by Type (2021-2026)
- 3.2 Global EMOCAP Forecasted Market Size by Type (2027-2032)
4 EMOCAP Breakdown Data by Application
- 4.1 Global EMOCAP Historic Market Size by Application (2021-2026)
- 4.2 Global EMOCAP Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global EMOCAP Market Perspective (2021-2032)
- 5.2 Global EMOCAP Growth Trends by Region
- 5.2.1 Global EMOCAP Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 EMOCAP Historic Market Size by Region (2021-2026)
- 5.2.3 EMOCAP Forecasted Market Size by Region (2027-2032)
- 5.3 EMOCAP Market Dynamics
- 5.3.1 EMOCAP Industry Trends
- 5.3.2 EMOCAP Market Drivers
- 5.3.3 EMOCAP Market Challenges
- 5.3.4 EMOCAP Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top EMOCAP Players by Revenue
- 6.1.1 Global Top EMOCAP Players by Revenue (2021-2026)
- 6.1.2 Global EMOCAP Revenue Market Share by Players (2021-2026)
- 6.2 Global EMOCAP Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of EMOCAP Head Office and Area Served
- 6.4 Global EMOCAP Players, Product Type & Application
- 6.5 Global EMOCAP Manufacturers Established Date
- 6.6 Global EMOCAP Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America EMOCAP Market Size (2021-2032)
- 7.2 North America EMOCAP Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America EMOCAP Market Size by Country (2021-2026)
- 7.4 North America EMOCAP Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe EMOCAP Market Size (2021-2032)
- 8.2 Europe EMOCAP Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe EMOCAP Market Size by Country (2021-2026)
- 8.4 Europe EMOCAP Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific EMOCAP Market Size (2021-2032)
- 9.2 Asia-Pacific EMOCAP Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific EMOCAP Market Size by Country (2021-2026)
- 9.4 Asia-Pacific EMOCAP Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America EMOCAP Market Size (2021-2032)
- 10.2 South America EMOCAP Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America EMOCAP Market Size by Country (2021-2026)
- 10.4 South America EMOCAP Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa EMOCAP Market Size (2021-2032)
- 11.2 Middle East & Africa EMOCAP Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa EMOCAP Market Size by Country (2021-2026)
- 11.4 Middle East & Africa EMOCAP Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 StretchSense
- 12.1.1 StretchSense Company Information
- 12.1.2 StretchSense Business Overview
- 12.1.3 StretchSense Revenue in EMOCAP Business (2021-2026)
- 12.1.4 StretchSense EMOCAP Product Portfolio
- 12.1.5 StretchSense Recent Developments
- 12.2 Noitom
- 12.2.1 Noitom Company Information
- 12.2.2 Noitom Business Overview
- 12.2.3 Noitom Revenue in EMOCAP Business (2021-2026)
- 12.2.4 Noitom EMOCAP Product Portfolio
- 12.2.5 Noitom Recent Developments
- 12.3 Vicon
- 12.3.1 Vicon Company Information
- 12.3.2 Vicon Business Overview
- 12.3.3 Vicon Revenue in EMOCAP Business (2021-2026)
- 12.3.4 Vicon EMOCAP Product Portfolio
- 12.3.5 Vicon Recent Developments
- 12.4 Cyber Glove Systems
- 12.4.1 Cyber Glove Systems Company Information
- 12.4.2 Cyber Glove Systems Business Overview
- 12.4.3 Cyber Glove Systems Revenue in EMOCAP Business (2021-2026)
- 12.4.4 Cyber Glove Systems EMOCAP Product Portfolio
- 12.4.5 Cyber Glove Systems Recent Developments
- 12.5 Rokoko
- 12.5.1 Rokoko Company Information
- 12.5.2 Rokoko Business Overview
- 12.5.3 Rokoko Revenue in EMOCAP Business (2021-2026)
- 12.5.4 Rokoko EMOCAP Product Portfolio
- 12.5.5 Rokoko Recent Developments
- 12.6 MANUS
- 12.6.1 MANUS Company Information
- 12.6.2 MANUS Business Overview
- 12.6.3 MANUS Revenue in EMOCAP Business (2021-2026)
- 12.6.4 MANUS EMOCAP Product Portfolio
- 12.6.5 MANUS Recent Developments
- 12.7 AiQ Synertial
- 12.7.1 AiQ Synertial Company Information
- 12.7.2 AiQ Synertial Business Overview
- 12.7.3 AiQ Synertial Revenue in EMOCAP Business (2021-2026)
- 12.7.4 AiQ Synertial EMOCAP Product Portfolio
- 12.7.5 AiQ Synertial Recent Developments
- 12.8 Virtual Motion Labs
- 12.8.1 Virtual Motion Labs Company Information
- 12.8.2 Virtual Motion Labs Business Overview
- 12.8.3 Virtual Motion Labs Revenue in EMOCAP Business (2021-2026)
- 12.8.4 Virtual Motion Labs EMOCAP Product Portfolio
- 12.8.5 Virtual Motion Labs Recent Developments
- 12.9 PhaseSpace
- 12.9.1 PhaseSpace Company Information
- 12.9.2 PhaseSpace Business Overview
- 12.9.3 PhaseSpace Revenue in EMOCAP Business (2021-2026)
- 12.9.4 PhaseSpace EMOCAP Product Portfolio
- 12.9.5 PhaseSpace Recent Developments
- 12.10 VRTRIX
- 12.10.1 VRTRIX Company Information
- 12.10.2 VRTRIX Business Overview
- 12.10.3 VRTRIX Revenue in EMOCAP Business (2021-2026)
- 12.10.4 VRTRIX EMOCAP Product Portfolio
- 12.10.5 VRTRIX Recent Developments
- 12.11 HaptX
- 12.11.1 HaptX Company Information
- 12.11.2 HaptX Business Overview
- 12.11.3 HaptX Revenue in EMOCAP Business (2021-2026)
- 12.11.4 HaptX EMOCAP Product Portfolio
- 12.11.5 HaptX Recent Developments
- 12.12 Virdyn
- 12.12.1 Virdyn Company Information
- 12.12.2 Virdyn Business Overview
- 12.12.3 Virdyn Revenue in EMOCAP Business (2021-2026)
- 12.12.4 Virdyn EMOCAP Product Portfolio
- 12.12.5 Virdyn Recent Developments
- 12.13 Qualisys AB
- 12.13.1 Qualisys AB Company Information
- 12.13.2 Qualisys AB Business Overview
- 12.13.3 Qualisys AB Revenue in EMOCAP Business (2021-2026)
- 12.13.4 Qualisys AB EMOCAP Product Portfolio
- 12.13.5 Qualisys AB Recent Developments
- 12.14 Xsens Technologyes
- 12.14.1 Xsens Technologyes Company Information
- 12.14.2 Xsens Technologyes Business Overview
- 12.14.3 Xsens Technologyes Revenue in EMOCAP Business (2021-2026)
- 12.14.4 Xsens Technologyes EMOCAP Product Portfolio
- 12.14.5 Xsens Technologyes Recent Developments
- 12.15 Optitrack
- 12.15.1 Optitrack Company Information
- 12.15.2 Optitrack Business Overview
- 12.15.3 Optitrack Revenue in EMOCAP Business (2021-2026)
- 12.15.4 Optitrack EMOCAP Product Portfolio
- 12.15.5 Optitrack Recent Developments
- 12.16 Codamotion
- 12.16.1 Codamotion Company Information
- 12.16.2 Codamotion Business Overview
- 12.16.3 Codamotion Revenue in EMOCAP Business (2021-2026)
- 12.16.4 Codamotion EMOCAP Product Portfolio
- 12.16.5 Codamotion Recent Developments
- 12.17 PTI Phoenix Technologies
- 12.17.1 PTI Phoenix Technologies Company Information
- 12.17.2 PTI Phoenix Technologies Business Overview
- 12.17.3 PTI Phoenix Technologies Revenue in EMOCAP Business (2021-2026)
- 12.17.4 PTI Phoenix Technologies EMOCAP Product Portfolio
- 12.17.5 PTI Phoenix Technologies Recent Developments
- 12.18 Noraxon USA
- 12.18.1 Noraxon USA Company Information
- 12.18.2 Noraxon USA Business Overview
- 12.18.3 Noraxon USA Revenue in EMOCAP Business (2021-2026)
- 12.18.4 Noraxon USA EMOCAP Product Portfolio
- 12.18.5 Noraxon USA Recent Developments
- 12.19 NTT Data
- 12.19.1 NTT Data Company Information
- 12.19.2 NTT Data Business Overview
- 12.19.3 NTT Data Revenue in EMOCAP Business (2021-2026)
- 12.19.4 NTT Data EMOCAP Product Portfolio
- 12.19.5 NTT Data Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst